NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma
Authors
Keywords
Diffuse large B cell lymphoma, NLRP3, Interleukin-18, Immune checkpoints, Immunosuppression
Journal
CANCER LETTERS
Volume 497, Issue -, Pages 178-189
Publisher
Elsevier BV
Online
2020-10-20
DOI
10.1016/j.canlet.2020.10.024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy
- (2020) Balamayoora Theivanthiran et al. JOURNAL OF CLINICAL INVESTIGATION
- CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model
- (2020) Suet Ling Felce et al. Frontiers in Oncology
- Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression
- (2020) Smriti Gurung et al. BIOMATERIALS
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Interleukin-18 in Health and Disease
- (2019) Koubun Yasuda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mechanisms Controlling PD-L1 Expression in Cancer
- (2019) Jong-Ho Cha et al. MOLECULAR CELL
- Dual inhibition of STAT1 and STAT3 activation downregulates expression of PD-L1 in human breast cancer cells
- (2018) Varun Sasidharan Nair et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma
- (2018) Li Li et al. BLOOD
- Role of the NLRP3 inflammasome in cancer
- (2018) Maryam Moossavi et al. Molecular Cancer
- Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases
- (2017) Si Ming Man et al. IMMUNOLOGICAL REVIEWS
- NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
- (2017) Donnele Daley et al. JOURNAL OF EXPERIMENTAL MEDICINE
- PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma
- (2017) V Atsaves et al. LEUKEMIA
- Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
- (2017) Y Liu et al. ONCOGENE
- The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines
- (2017) Toshifumi Doi et al. ONCOLOGY REPORTS
- NLRP3 inflammasome activation plays a carcinogenic role through effector cytokine IL-18 in lymphoma
- (2017) Xia Zhao et al. Oncotarget
- Inflammasomes and Cancer
- (2017) Rajendra Karki et al. Cancer Immunology Research
- T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells
- (2016) I. Azzaoui et al. BLOOD
- Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab
- (2016) M. Sade-Feldman et al. CLINICAL CANCER RESEARCH
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma
- (2015) J. Kiyasu et al. BLOOD
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Regulatory T cells in cancer immunotherapy
- (2014) Hiroyoshi Nishikawa et al. CURRENT OPINION IN IMMUNOLOGY
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- IFN-γ-Stimulated Neutrophils Suppress Lymphocyte Proliferation through Expression of PD-L1
- (2013) Stan de Kleijn et al. PLoS One
- Inflammasomes in carcinogenesis and anticancer immune responses
- (2012) Laurence Zitvogel et al. NATURE IMMUNOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
- (2010) Christian Gisselbrecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma
- (2009) Adi Broyde et al. AMERICAN JOURNAL OF HEMATOLOGY
- Overexpression of Interleukin-1β Induces Gastric Inflammation and Cancer and Mobilizes Myeloid-Derived Suppressor Cells in Mice
- (2008) Shuiping Tu et al. CANCER CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started